FEATURED PRODUCTS

• Protein L Resin For Affinity Capture

  MabSelect™ VL resin — protein L resin for affinity capture of antibody Fabs, bispecifics, and other variants containing a kappa light chain.

• Hyclone Cell Boost Supplements

  Supplements cell culture with amino acids, vitamins, and glucose and manufactured to meet cGMP manufacturing standards and QC specifications.

• Chromatography Systems

  ÄKTA™ chromatography systems can handle both simple and complex purification tasks and accelerate daily routines. All systems are controlled by UNICORN™ software, a common control platform and user interface for all scales of operation. 

• Bioprocessing Filtration

  Cytiva provides filtration solutions and support for integrated bioprocessing applications at every step and every scale of the drug development, validation and manufacturing process.

• Label-Free Interaction Analytics

  We offer a range of systems, accessories, and reagents for label-free analysis using microcalorimetry or surface plasmon resonance (SPR). These techniques provide information-rich, real time data without the use of labels.

• A High-Capacity Chromatography Resin For Robust mAb Capture

  Protein A chromatography resin with excellent capacity and alkaline stability for cost-efficient and extremely robust mAb capture.

• Drug Product Filtration System

  Automated PUPSIT and sterile filtration with enhanced product recovery.

• Protein A Resin With High Binding Capacity

  Protein A resin with high binding capacity for cost-efficient separation mAbs.

• Modular Environments For Biomanufacturing Capacity

  Accelerate your biomanufacturing capacity with purpose-built modules

  KUBio™ box modular bioprocessing environments are designed to help biopharmaceutical manufacturers bring high-quality biopharmaceuticals to market more quickly. By reducing typical design and construction times and streamlining process execution, they support future expansion and replication needs. Available KUBio™ box modular environments for biosafety levels 1 and 2 (BSL-1 and BSL-2) can be delivered in 10 to 15 months for implementation inside existing infrastructure. The result? Reduced project risk, accelerated delivery of next-gen therapies, and greater flexibility at different production scales and product technologies.

• Process Trains For Flexible, Configurable Biopharma Manufacturing Capacity

  Transform your space to fit your needs

  Configurable FlexFactory™ biomanufacturing process trains can help scientists better control the production and processing of different viral vectors and new modalities—all within the same space. Plan your agile manufacturing strategy with greater efficiency and integration to address current and future capacity needs.